Evaluation of FKBP5 as a cortisol activity biomarker in patients with ACTH-dependent Cushing syndrome

Evaluation of FKBP5 as a cortisol activity biomarker in patients with ACTH-dependent Cushing syndrome

Purpose: To evaluate the performance of FKBP5 as a cortisol activity biomarker in patients with ACTH-dependent Cushing syndrome (CS). Methods: This was a prospective, multicenter, nonrandomized, noninterventional study of a cortisol activity biomarker in adult patients (≥18 years) with documented AC...

Full description

Bibliographic Details
Main Authors:	Irina Bancos, Betul Ayse Hatipoglu, Kevin C.J. Yuen, Lakshmi Chandramohan, Sandeep Chaudhari, Andreas G. Moraitis
Format:	Article
Language:	English
Published:	Elsevier 2021-03-01
Series:	Journal of Clinical & Translational Endocrinology
Subjects:	FKBP5 Biomarker Cushing syndrome Cortisol activity
Online Access:	http://www.sciencedirect.com/science/article/pii/S2214623721000089

Similar Items

The frequency of Cushing's disease, ACTH-independent Cushing's syndrome and autonomous cortisol secretion among Turkish patients with obesity
by: Reşit Volkan Atar, et al.
Published: (2020-05-01)

Concomitant coexistence of ACTH‐dependent and independent Cushing syndrome
by: Ach Taieb, et al.
Published: (2022-05-01)

The role of intrа- and postoperative ACTH and cortisol levels measurement in patients with Cushing’s disease as an early predictors of remission
by: Elena Y. Nadezhdina, et al.
Published: (2017-07-01)

Prognostic usefulness of ACTH in the postoperative period of Cushing’s disease
by: Pablo Abellán-Galiana, et al.
Published: (2019-09-01)

Metabolic profile differences in ACTH‐dependent and ACTH‐independent Cushing syndrome
by: Zhengyang Li, et al.
Published: (2022-03-01)

Intraocular pressure and its correlation with midnight plasma cortisol level in Cushing's disease and other endogenous Cushing's syndrome
by: Priyadarshini Mishra, et al.
Published: (2017-01-01)

ACTH-independent Cushing’s syndrome with bilateral cortisol-secreting adrenal adenomas: a case report and review of literatures
by: Jia Wei, et al.
Published: (2018-04-01)

Endocrine hypertension - Cushing′s syndrome
by: Yashpal Singh, et al.
Published: (2011-01-01)

Cortisol and Phosphate Homeostasis: Cushing’s Syndrome Is Associated With Reversible Hypophosphatemia
by: Ariadne Bosman, et al.
Published: (2021-09-01)

Midnight salivary cortisol, measured by highly sensitive electrochemiluminescence immunoassay, for the diagnosis of Cushing’s syndrome
by: Yaneva Maria, et al.
Published: (2009-03-01)

Eyelid edema due to Cushing's syndrome
by: Koichiro Yamamoto, et al.
Published: (2022-06-01)

Late-night salivary cortisol and cortisone should be the initial screening test for Cushing’s syndrome
by: Ramjan Sanas Mohamed, et al.
Published: (2022-06-01)

Type 2 diabetes and cardiometabolic risk may be associated with increase in DNA methylation of FKBP5
by: Robin Ortiz, et al.
Published: (2018-06-01)

Spot urine cortisol-creatinine ratio - A useful screening test in the diagnosis of Cushing′s syndrome
by: Nitin Kapoor, et al.
Published: (2012-01-01)

Adrenocorticotropic hormone (ACTH) independent Cushing´s syndrome due to unilateral adrenocortical hyperplasia: two case reports
by: Yousra Aouinati, et al.
Published: (2021-04-01)

Adrenocorticotropic Hormone-Independent Cushing Syndrome with Bilateral Cortisol-Secreting Adenomas
by: Eu Jeong Ku, et al.
Published: (2013-06-01)

Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
by: Rosario Pivonello, et al.
Published: (2021-07-01)

Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study
by: Rosario Pivonello, et al.
Published: (2022-04-01)

Editorial: Insights in Cushing’s syndrome and disease, volume II
by: Fabienne Langlois
Published: (2024-10-01)

High prevalence of vertebral fractures associated with preoperative cortisol levels in patients with recent diagnosis of Cushing disease
by: Heng Sun, et al.
Published: (2023-12-01)

Trilostane monitoring in canine hyperadrenocorticism: can basal cortisol measurement replace the ACTH stimulation test?
by: Theodora Tsouloufi, et al.
Published: (2021-09-01)

Cushing’s syndrome with no clinical stigmata – a variant of glucocorticoid resistance syndrome
by: Ved V. Gossain, et al.
Published: (2018-12-01)

Cushing Disease Treated Successfully With Metyrapone During Pregnancy
by: Ilana Ramer Bass, MD, MPH, et al.
Published: (2022-03-01)

Psychotic symptoms in Cushing’s syndrome secondary to ACTH-secreting lung carcinoid tumor: report of a case
by: A. Llimona González, et al.
Published: (2022-06-01)

ALK2 Receptor Kinase Association with FKBP12.6 Is Structurally Conserved with the ALK2-FKBP12 Complex
by: Eleanor Williams, et al.
Published: (2021-01-01)

Biological Actions of the Hsp90-binding Immunophilins FKBP51 and FKBP52
by: Nadia R. Zgajnar, et al.
Published: (2019-02-01)

Síndrome de Cushing ACTH-dependiente durante el embarazo tratado con metirapona
by: Catarina Machado, et al.
Published: (2021-04-01)

Management of Cushing’s disease when surgery is a tricky option – a case report
by: Lucija Vusić, et al.
Published: (2023-01-01)

A case of autonomous cortisol secretion in a patient with subclinical Cushing’s syndrome, GNAS mutation, and paradoxical cortisol response to dexamethasone
by: Chihiro Sakaguchi, et al.
Published: (2019-01-01)

A study of thyroid functions in patients with Cushing’s syndrome: a single-center experience
by: Boni Xiang, et al.
Published: (2019-08-01)

Pharmacological Modulation of the Psychiatric Risk Factor FKBP51 Alters Efficiency of Common Antidepressant Drugs
by: Max L. Pöhlmann, et al.
Published: (2018-11-01)

Glucocorticoid-Responsive Transcription Factor Krüppel-Like Factor 9 Regulates fkbp5 and Metabolism
by: Ian M. Gans, et al.
Published: (2021-10-01)

Behavioral, Physiological, and Pathological Approaches of Cortisol in Dogs
by: Sorin Marian Mârza, et al.
Published: (2024-12-01)

Screening for Cushing's syndrome in obese patients
by: Ozay Tiryakioglu, et al.
Published: (2010-01-01)

Salivary cortisol as a tool for physiological studies and diagnostic strategies
by: Castro M., et al.
Published: (2000-01-01)

Multiple Salivary Cortisol Measurements Are a Useful Tool to Optimize Metyrapone Treatment in Patients with Cushing’s Syndromes Treatment: Case Presentations
by: Kenichi Yoshida, et al.
Published: (2018-01-01)

Lean Cushing's
by: Yashendu Sarda, et al.
Published: (2020-01-01)

Neuropsychiatric symptoms in a patient with Cushing’s syndrome
by: Reyna Daya, et al.
Published: (2022-01-01)

RETRACTED: Hsp90‐binding immunophilin FKBP51 forms complexes with hTERT enhancing telomerase activity
by: Mariana Lagadari, et al.
Published: (2016-08-01)

A pitfall of bilateral inferior petrosal sinus sampling in cyclic Cushing’s syndrome
by: Adriana Albani, et al.
Published: (2019-10-01)